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Introduction
The diagnosis of primary hyperparathyroidism (pHPT) is based
on the finding of normal/high blood calcium levels associated to
inadequately high/normal parathyroid hormone (PTH) circulat-
ing levels. The majority of cases of pHPT are currently repre-
sented by asymptomatic/paucisymptomatic forms of the dis-
ease, with little or no progression (1). Moreover, pHPT is char-
acterized by recurrent kidney stones and osteoporosis, disor-
ders frequently observed in the normal population, indepen-
dently from parathyroid diseases. Surgery is indicated in cases
of symptomatic pHPT, while in mild forms of the disease a con-
servative approach may be chosen (2). 
Imaging localization of enlarged parathyroid glands is used in
the preoperative detection and spatial assessment of a patho-
logic parathyroid glands (3). When clinical and biochemical re-
sults do not fully support the diagnosis of pHPT, imaging stud-
ies may lead to false diagnosis.
In the present report we describe the clinical history of two pa-
tients suspected to be affected by pHPT, whose imaging data
were superimposable, but final diagnosis was different. 
Case 1
A 63-year-old woman was referred to the Mineral Metabolic
Unit by her family doctor with a history of recurrent kidney
stones and persistent pHPT, having previously undergone
surgery on the basis of clinical and imaging findings suggesting
the presence of a parathyroid adenoma. 
In the past history of the patient, diagnosis of normocalcemic
symptomatic pHPT was made by her family doctor, which re-
quested a scintigraphy with 99Tc-MIBI and a neck-thoracic CT.
Biohumoral data showed elevated circulating PTH (1-84) levels
(88 pg/ml; N.V. = 10-70 pg/ml), normal blood total calcium (9.2
mg/dl; N.V. = 8.8-10.4 mg/dl) and increased urine calcium ex-
cretion (385 mg/die; N.V. = 100-300 mg/die). Hip and lumbar
bone densities showed the presence of osteoporosis (neck
BMD: T-score -2.5, lumbar BMD: T-score = -2.7); a previous
exam (5 years earlier) showed the presence of osteopenia
(lumbar T-score = -2.2).
The scintigraphy showed a large mediastinic non homogenous
area of uptake visualized also in delayed (2 hours) images
(Fig. 1b), suspecting the presence of pathologic parathyroid tis-
sue. CT-scan confirmed the presence of a conspicuous mass
(diameter 4x5x5 cm) in the mediastinum, with the upper ex-
tremity contiguous to the inferior pole of the right lobe of the
thyroid gland (Fig. 1c). Post-contrastographic enhancement
was very poor. Without hypotheses on the nature of the mass
its localization well-matched with a pathologic ectopic parathy-
roid gland.
The patient underwent surgery for removal of the suspected
parathyroid adenoma. At surgery, no evidence of pathologic PT
gland(s) could be found and histopathology of the mass
showed evidence of sarcoid lymphonodal mass, with persistent
pHPT after surgery.
During a recent ultrasound (US) kidney evaluation, the radiolo-
gist examined the neck, where a large nodular lesion was
found caudally to the inferior pole of the right lobe of the thy-
roid, extending into the anterior mediastinum, and its parathy-
roid origin was suggested (Fig. 1a).
A careful clinical evaluation led to the following data. The pa-
tient had no family history of kidney stones, osteoporosis, frac-
tures or other related diseases. She underwent menopause
when she was 54 year-old. A vague abdominal pain and de-
pression were present for many years. The patient never com-
plained of respiratory symptoms. She was not assuming any
chronic medical therapy.
Biohumoral data showed absence of activation of the indexes
of bone turnover. Routine blood and urine testing and creati-
nine clearance were in the normal range. 
Measurement of blood and urine calcium on three different
days on a diet containing 1 gr/day of calcium and 100
mEq/day of sodium, showed serum levels of ionized calcium
in the normal range (4.5-4.7 mg/dl, N.V. = 4.2-5.3), total
serum calcium in the low-normal range (8.7-9.2 mg/dl) and
urinary calcium higher than normal (380-500 mg/day). Serum
phosphorus levels were 3.5 mg/dl (N.V. = 2.5-4.5) with nor-
mal total serum protein (7.0 mg/dl; N.V. = 6-8) and modestly
elevated circulating PTH levels (70-90 pg/ml). Both 25(OH)
vitamin D and 1,25(OH)2 vitamin D levels were in the normal
range (respectively 22 ng/ml; N.V. = 12-55 ng/ml and 42
pg/ml; N.V. = 20-70 pg/ml). Urinary oxalate levels were nor-
mal. 
Therefore, the results of the biohumoral exams did not confirm
the suspect of pHPT, and primary hypercalciuria was consid-
ered the most likely cause of kidney stones, with increased
bone loss and secondary hyperparathyroidism. Indeed, the
presence of a mixed, absorptive and renal hypercalciuria was
Clinical Cases in Mineral and Bone Metabolism 2005; 2(1): 61-63 61
Diagnosis of primary hyperparathyroidism:
bias of imaging evaluation in the absence of accurate
clinical evaluation
Brief report
©
 C
IC
 E
DI
ZI
ON
I I
NT
ER
NA
ZI
ON
AL
I
confirmed in this patient by specific testing and PTH circulating
levels returned to normal after four months of appropriate med-
ical therapy and dietary intervention.
Case 2
A 43 year old man was evaluated for a two year history of re-
current kidney stones with the suspect of pHPT.
Measurement of blood and urine calcium in three different days
on a diet containing 1 gr/day of calcium and 100 mEq/day of
sodium showed circulating total calcium and PTH (1-84) levels
at the upper limits (respectively, 10.4 and 10.8 mg/dl and 68
and 73 pg/ml). Blood levels of ionized calcium were frankly ele-
vated (5.5-5.7 mg/dl, N.V. 4.2-5.3 mg/dl), serum phosphorus
levels were low (1.9-2.2 mg/dl, N.V. = 2.5-4.5 mg/dl), and total
serum protein levels were in the normal range. Urine calcium
excretion was increased (450-530 mg/24 hr) and biohumoral
data showed activation of the indexes of bone turnover.
Lumbar bone density showed the presence of osteoporosis
(lumbar BMD: T-score = -2.63).
All the above data supported the diagnosis of normocalcemic
symptomatic pHPT.
Imaging studies were requested in order to detect and define
the morphovolumetric assessment of the pathologic PT
gland(s), before surgical removal.
99Tc-MIBI scintigraphy showed a mediastinic uptake area, also
detected in delayed (2 hours) images (Fig. 2b). US and CT-
scan demonstrated a 3.5x4x4 cm mediastinic mass contiguous
to the inferior pole of the left lobe of the thyroid gland (Fig. 2a
and 2c). Post-contrastographic CT-scan showed a strong en-
hancement. No hypotheses on the characterization of the mass
were suggested, however, its localization was suitable with a
pathologic ectopic parathyroid gland.
The patient underwent surgery for removal of the suspected
parathyroid adenoma. Surgical and histopathologic data con-
firmed the presence of the parathyroid adenoma. Biochemical
testing two and eight weeks after surgery, revealed normal
PTH levels (50-45 pg/ml) with normocalcemia (9-9.3 mg/dl),
normophosphoremia (3.8-4 mg/dl), and normocalciuria (240
and 200 mg/24 hours).
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Figure 1 - Patient 1: sarcoidotic lymph node.A) Ultrasound: at the infrajugular right parasagittal site is present a scarcely echoic, huge mass with
sharp edges. B) 99TcMIBI Scintigraphy: image obtained 90 min after injection of the tracer; a “hot” spot is shown in the upper mediastinum-low neck.
C) Computed tomography: on the right side of esophagus and trachea, a scarcely contrast- enhanced mass is present.
A B C
Figure 2 - Patient 2: parathyroid adenoma.A) Ultrasound: at the infrajugular left parasagittal site a scarcely echoic mass, with sharp edges is present. B)
99TcMIBI Scintigraphy: image obtained 90 min. after injection of the tracer; a “hot” spot is shown in the left upper mediastinum-low neck. C) Computed to-
mography: a strongly contrast-enhanced spherical mass was visible in the left side of the esophagus between the trachea and a vertebral body.
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Discussion
The diagnosis of pHPT is based on the finding of normal/high
serum calcium levels inadequately associated to circulating
PTH values at the upper limit or higher than normal (4). The
clinical presentation of pHPT is variable, with asymptomatic/
paucisymptomatic normocalcemic cases being now more fre-
quent than classic symptomatic cases (1). The presence of de-
pression and abdominal symptoms is often reported by these
patients. 
Modest increase in circulating PTH levels are a common find-
ing in postmenopausal women due to widespread screening for
menopausal osteoporosis. Often these PTH modifications re-
veal normocalcemic asymptomatic pHPT without specific indi-
cation for surgery.
Cases of pHPT with recurrent kidney stones often show serum
total calcium levels in the upper limit of normal (10.0 and 10.5
mg/dl), high ionized calcium levels, modest increases of PTH,
and hypercalciuria. The finding of modest increases of circulat-
ing PTH in the presence of normal ionized calcium and total
serum calcium level in the low-normal range is not indicative
for pHPT. The presence of hypercalciuria suggests the possi-
bility of idiopathic hypercalciuria (IH). 
The diagnosis of pHPT relies only on clinical and laboratory da-
ta, even though often pHPT patients are referred to specialized
Centers with poor clinical and biochemical evaluation, but with
an unnecessary and expensive imaging documentation. In-
deed, imaging studies have a primary role only in the presurgi-
cal detection and spatial assessment of a pathologic parathy-
roid tissue.
Imaging of pathologic parathyroid nodules can be difficult due
to the differences in size (from undetectable by US, CT or MR
techniques to large nodules) and the variability in the location
of the glands in the neck or mediastinum (due to the embry-
ologic origin). Moreover, the presence of nodules in the neck is
a common finding during routinary US examination, and the
imaging techniques currently available cannot provide specific
diagnostic criteria useful for the recognition of parathyroid tis-
sue (3). The combination of US and dual phase 9 9 mT c - M I B I ,
both having a high sensitivity and specificity, leads to an im-
provement of sensitivity, negative predictive value, and accura-
cy, with no decrease of the high specificity and positive predic-
tive value with respect to each single technique (4). In fact,
scintigraphic positivity is able to clarify the cases of lack of US
characterization, while US is able to detect small glands that
can be missed by scintigraphy due to small dimensions, low
metabolic activity or presence of necrotic or cystic areas. It is
important to emphasize that dual phase 9 9 mTc-MIBI scintigra-
phy has high (4-6) accuracy in differentiating thyroid vs
parathyroid nodules. However, 99mTc-MIBI scintigraphy can be
considered a generic “cellular activity marker” and its positivity
can be due to many pathologies such as mammary cancer,
lymphomas, flogistic lymph nodes, and Hurtle cell adenoma
(5). On the other hand US and CT provide high sensitivity in lo-
cating the pathologic glands also if ectopic (neck and medi-
astinum). A strong enhancement on post-contrastographic CT,
indicating the presence of a high vascularity is present only in
some cases of PT pathologic glands and nodules of different
nature can exhibit similar enhancement ratio. Therefore the in-
tensity of CT enhancement cannot be considered an unam-
biguous characterization criteria for parathyroid enlarged gland. 
On the basis of these considerations imaging procedure, while
representing a fundamental tool for the surgeon, can lead to
wrong diagnostic conclusions when clinical and laboratory data
are not evaluated by experienced specialists in Mineral Metab-
olism.
Patient 1 is a clear example of these limitations. In fact, a histo-
ry of recurrent kidney stones with hypercalciuria, high PTH lev-
els, osteoporosis, depression and abdominal pain could be
evocative of pHPT. However, the absence of increased serum
ionized calcium levels associated to normal phosphorus and
total calcium level in the low-normal range in a patient suffering
from renal stones for the past 25 years has to pose the suspect
of IH. In this condition PTH increase is secondary to hypercal-
ciuria which causes kidney stone disease and osteoporosis
(7,8). The information derived from imaging techniques did not
help the primary care physician to reach a correct diagnosis.
On the contrary the recognition of a mediastinal mass led to
major thoracic surgery for a sarcoidotic lymph node, that could
have been treated conservatively.
In patient 2 the clinical and laboratory data showed an unequiv-
ocal diagnosis of symptomatic pHPT, as indicated by high cir-
culating ionized calcium levels and inappropriately elevated
PTH levels. In this case imaging findings guided the surgeon to
the ablation of pathologic PT tissue.
In conclusion, the diagnosis of pHPT must be based on clinical
and laboratory data. Imaging studies do not add useful diag-
nostic information, having, however, a role in the presurgical
etection of enlarged parathyroid gland(s). The use of imaging
studies to clear doubts in clinical diagnosis of pHPT may in-
deed lead to wrong therapeutical choices.
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